Delivery Order SPE2DE24D0013-SPE2D625F3NPQ

The U.S. Defense Logistics Agency (operating under the Medical Supply Chain division) awarded a firm fixed-price delivery order valued at $6,800 to Cepheid Inc. for molecular diagnostic solutions on September 16, 2025, with completion scheduled for September 23, 2025. This delivery order, designated as XPCOV2/FLU/RSV-10, carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of diagnostic testing capabilities. The work will be performed at Cepheid's primary facility in Sunnyvale, California, and focuses on diagnostic systems and reagents for detecting COVID-19, influenza, and respiratory syncytial virus (RSV)—key infectious disease threats prioritized within federal healthcare and defense medical systems.

This delivery order likely draws from one of Cepheid's two significant Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs, most notably the $32.8 million single-award IDV with VA's Veterans Integrated Service Network 6, which provides molecular diagnostic testing system reagents and assays through September 2030. Cepheid is an established federal contractor specializing in advanced molecular diagnostic technologies and GeneXpert diagnostic systems, having demonstrated consistent capability in delivering diagnostic equipment, reagent supplies, and testing services across multiple federal healthcare and defense agencies. The relatively modest ceiling value of this delivery order reflects typical task order sizing under larger IDV vehicles, ensuring continued access to critical diagnostic capabilities for infectious disease detection across the federal health system.